Nimenrix Dosing and Administration

Nimenrix (Meningococcal groups A, C, W135 and Y conjugate vaccine) is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal disease caused by Neiserria meningitidis serogroups A, C, W135 and Y.*,†,1

Nimenrix dosing schedule:*,†,1


Route of administration1

  • Immunisation should be carried out by intramuscular injection only
  • The recommended injection site is the anterolateral aspect of the thigh in infants. The anterolateral aspect of the thigh or deltoid muscle is the recommended injection site for individuals from 1 year of age

*See prescribing information for further information

Nimenrix should be used in accordance with official recommendations


Nimenrix™ is available as a single pack with two needles for reconstitution and administration (23G blue and 25G orange, 25mm).2 Nimenrix comes as a powder in a vial, with a solvent for solution for injection in a pre-filled syringe. These components require reconstitution prior to administration.1


Visuals adapted from visuals sourced from

Click here to download the Nimenrix administration guide

How should Nimenrix be stored?1

Before reconstitution – Nimenrix should be stored in the refrigerator between 2°C and 8°C in its original packaging. It has a shelf life of 4 years, but the expiry date on the packaging should always be checked prior to use. 

After reconstitution – Nimenrix should be used promptly following reconstitution. Although delay is not recommended, stability has been demonstrated for 8 hours at 30°C after reconstitution. If the vaccine is not used within 8 hours, it should not be administered.


1. Nimenrix. Summary of Product Characteristics, United Kingdom, Pfizer Ltd. Available here
2. Pfizer data on file, February 2020.

Prescribing Information
Nimenrix™ prescribing information.


PP-NIM-GBR-0219.  June 2020